ArticleActa gastroenterologica Latinoamericana
[Diagnostic Methods for the Detection of
Article in Acta gastroenterologica Latinoamericana. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Diagnostic Methods for the Detection ofActa gastroenterologica LatinoamericanaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric infection by Helicobacter pylori has a variable prevalence worldwide. In Latin America, it can exceed 50% of infected people. It is associated with peptic ulcer, gastric cancer, MALT lymphoma, immune thrombocytopenic purpura, among other pathologies. There is no optimal diagnostic method, and its presence can be detected by both invasive methods that require an upper gastrointestinal endoscopy, and non-invasive methods. Within the invasive, we have the rapid urease test, histology, molecular tests such as polymerase chain reaction and culture. On the other hand, non-invasive tests include the breath test, Helicobacter pylori antigen in stools, polymerase chain reaction in stools and serology. Depending on the clinical scenario, the diagnostic test to be used, its benefits and weaknesses should be known. It is important to consider the age of the patient, their gastric cancer risk factors, the need for endoscopy for this or another reason, the availability of diagnostic tests and the cost, among others.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.